ALNFL.PA
NFL Biosciences SA [ALNFL.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALNFL.PA Stock Summary
Top 10 Correlated ETFs
ALNFL.PA
Top 10 Correlated Stocks
ALNFL.PA
In the News
ALNFL.PA Financial details
Company Rating
-
Market Cap
20.83M
Income
-6.19M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
05 Oct 2023
P/E
-3.51
Forward P/E
-
PEG
-0.35
P/S
-
P/B
10.16
P/C
-
P/FCF
-
Quick Ratio
0.78
Current Ratio
1.46
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.94
EPS next Y
-
EPS next Q
-
EPS this Y
-2.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-28.57%
-
-
-
-
SMA20
-7.41%
SMA50
-16.67%
SMA100
-20.63%
Inst Own
-
Inst Trans
-
ROA
-102%
ROE
-118%
ROC
-3.65%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.94-3.32
52W High
-
52W Low
-
RSI
59.13
Rel Volume
1.17
Avg Volume
55.19K
Volume
64.41K
Perf Week
22.46%
Perf Month
2.42%
Perf Quarter
-17.96%
Perf Half Y
-18.36%
-
-
-
-
Beta
1.7743
-
-
Volatility
0.17%, 0.13%
Prev Close
-8.65%
Price
1.69
Change
11.92%
Company Profile
- Volume Average 55.19K
- Market Capitalization 20.83M
- Employee 4
- CEO Dr. Ignacio Faus M.B.A., Ph.D.
- Headquarters Castelnau-le-Lez,FR
- IPO Date 2021-07-05
-
Website
https://www.nflbiosciences.com 
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
